Literature DB >> 1150346

Origin and partial characterization of Fc receptor-bearing cells found within experimental carcinomas and sarcomas.

R S Kerbel, H F Pross, E V Elliott.   

Abstract

A variety of murine connective and epithelial tissue tumors, including the SAD/2 and FS9 fibrosarcomas, the TA3/Ha and CAD/2 mammary carcinomas and a primary methylcholanthrene-induced sarcoma, were found to contain a high proportion of cells with receptors for the Fc portion of immunoglobulin G ("Fc receptors"). Experiments were undertaken to assess whether these cells were neoplastic, or whether they represented the infiltration into the tumor of non-malignant host cells such as macrophages or lymphocytes. It was found that long-term established in vitro cell lines of the TA3/Ha SAD/2 and CAD/2 tumors were entirely negative for the Fc receptor, whereas injection of these cells led to the formation of tumors containing a high proportion of Fc receptor-bearing cells. Many of these cells were actively phagocytic as assessed by ingestion of iron filings or antibody-coated erythrocytes. Injection of Fc receptor-negative cultured tumor cells into F1 hybrids, in which host cells could be distinguished from the tumor cells by anti-H2 sera, revealed that many or all of the Fc receptor-bearing cells in the resultant tumor were of host origin. In contrast to its effect on normal spleen cells, anti-theta serum treatment also partially inhibited Fc rosettes, suggesting a T-lymphocyte origin for some of the Fc receptor-bearing cells. Since almost all cells with potential anti-tumor activity bear Fc receptors, it is suggested that an index of host cell infiltration of carcinomas and sarcomas can quickly and easily be ascertained by enumeration of Fc receptor-bearing cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1150346     DOI: 10.1002/ijc.2910150607

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

Review 1.  Disordered function of mononuclear phagocytes in malignant disease.

Authors:  R J Sokol; G Hudson
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

2.  Surface markers of small lymphocytes appearing in the mouse Ehrlich ascites tumour, host spleen and blood.

Authors:  S Garnis; P K Lala
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

3.  Rapid adsorption of a foetal calf serum component by mammalian cells in culture. A potential source of artifacts in studies of antisera to cell-specific antigens.

Authors:  R S Kerbel; D Blakeslee
Journal:  Immunology       Date:  1976-12       Impact factor: 7.397

4.  [Effector function of acute leukemias in "spontaneous" (SCMC) and antibody dependent cellular cytotoxicity-tests (ADCC) (author's transl)].

Authors:  P Schmidt; H H Peter; J R Kalden; H J Avenarius; H Bodenstein
Journal:  Klin Wochenschr       Date:  1978-10-01

5.  Myeloid cell transformation by ras-containing murine sarcoma viruses.

Authors:  J H Pierce; S A Aaronson
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

6.  Activity of antibodies recovered from immune complexes of ovarian cancer patients.

Authors:  P M Lutz; J R Dawson
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

7.  Anti-(human LFA-1) monoclonal antibodies bind P815 murine tumour cells.

Authors:  M J Palisson; A Altemeyer; I Moosbrugger; S Warter; G Hauptmann; P Bischoff
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

8.  Immunocompetent cells in malignant disease in man. II. Clinical and immunologic correlates in a case of non-Hodgkin's lymphoma.

Authors:  D Algom; E Rapp; H Hamdy; M A Keaney; W Hirte; D J Klaassen; M Richter
Journal:  Can Med Assoc J       Date:  1978-01-21       Impact factor: 8.262

Review 9.  Tumor progression in metastasis: an experimental approach using lectin resistant tumor variants.

Authors:  R S Kerbel; J W Dennis; A E Largarde; P Frost
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

Review 10.  Macrophages and neoplasms: new insights and their implication in tumor immunobiology.

Authors:  R Evans
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.